Isleworth Healthcare Acquisition Corp. (ISLE)
|Net Income (ttm)||4.15M|
|Day's Range||9.94 - 9.95|
|52-Week Range||9.67 - 9.95|
Isleworth Healthcare Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire a business in the biopharmaceutical or medical technology/device industries. The company was incorporated in 2020 and is based in Saint Petersburg, Florida. [Read more...]
Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK™ Cell Engager antibody at EHA 2022 Con...
Data supports further development of CYT-338 in relapsed/refractory multiple myeloma AVENTURA, Fla. and NATICK, Mass.
Cytovia Therapeutics to Present In Vivo Multiple Myeloma Data of its CD38-Targeting Flex-NK™ Cell Engager at EHA 2022...
AVENTURA, Fla. and NATICK, Mass.
Cytovia Therapeutics to Present at AACR Special Conference on Advances in the Pathogenesis and Molecular Therapies of...
AVENTURA, Fla. and NATICK , Mass.
Isleworth Healthcare Acquisition Corp. Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report
ST. PETERSBURG, Fla., June 3, 2021 /PRNewswire/ -- Isleworth Healthcare Acquisition Corp. (NASDAQ: ISLE) (the "Company") announced today announced that on May 28, 2021 it received a notice ("Notice") fr...
ST. PETERSBURG, Fla., March 25, 2021 /PRNewswire/ -- Isleworth Healthcare Acquisition Corp. (NASDAQ: ISLEU) (the "Company") announced today that, on March 29, 2021, the Company's units will no longer tr...